Environmental Health Perspectives 102, Supplement 7, November 1994
The Biochemical Effects of Physiologic Amounts of Dietary Boron in Animal Nutrition Models
Curtiss D. Hunt
United States Department of Agriculture, Agricultural Research Service, Grand Forks, North Dakota
Abstract
This review summarizes evidence that supports working hypotheses for the roles of boron in animal model systems. It is well established that vascular plants, diatoms, and some species of marine algal flagellates have acquired an absolute requirement for boron, although the primary role of boron in plants remains unknown. Recent research findings suggest that physiologic amounts of supplemental dietary boron (PSB) affect a wide range of metabolic parameters in the chick and rat model systems. Much of the current interest in boron animal nutrition began with the initial finding that PSB stimulates growth in cholecalciferol (vitamin D
3)-deficient chicks, but does not markedly affect growth in chicks receiving adequate vitamin D
3 nutriture. The finding suggests that boron affects some aspect of vitamin D
3 metabolism or is synergistic with vitamin D
3 in influencing growth. Vitamin D
3 regulates energy substrate utilization, and current research findings indicate that dietary boron modifies that regulatory function. The concentration of circulating glucose, the most thoroughly investigated metabolite to date, responds to PSB, especially during concomitant vitamin D
3 deficiency. In chicks, PSB substantially alleviated or corrected vitamin D
3 deficiency-induced elevations in plasma glucose concentrations. The influence of vitamin D
3 on cartilage and bone mineralization is mediated in part through its role as a regulator of energy substrate utilization; calcification is an energy-intensive process. There is considerable evidence that dietary boron alleviates perturbations in mineral metabolism that are characteristic of vitamin D
3 deficiency. In rachitic chicks, PSB alleviated distortion of the marrow sprouts of the proximal tibial epiphysial plate, a distortion characteristic of vitamin D
3 deficiency.
In ovo injections of boron or 1,25-(OH)
2-vitamin D
3 reduced the abnormal height of the growth plate of 1-day-old chicks hatched from vitamin D
3-deficient eggs. Also, in vitamin D-deficient rats, PSB improved the apparent absorption and retention of calcium and phosphorus, and increased femur magnesium concentrations. Current findings lend support to the hypothesis that boron alleviates the symptoms of vitamin D
3-deficiency by enhancing utilization or sparing minimal supplies of an active vitamin D
3 metabolite. Also, boron and vitamin D
3 have the same overall effect on the local utilization of energy substrates. A corollary of the hypothesis is that some of the effects of dietary boron will be overshadowed by the effects of adequate amounts of dietary vitamin D
3. --
Environ Health Perspect 102(Suppl 7):35-43 (1994).
Key words: boron, vitamin D3, boron analysis, rats, chickens, energy substrate utilization, glucose, growth cartilage, mineral metabolism, calcium, magnesium, boron, homeostasis
This paper was presented at the International Symposium on Health Effects of Boron and Its Compounds held 16-17 September 1992 at the University of California, Irvine, California.
Address correspondence to Dr. C. D. Hunt, USDA, ARS, GFHNRC, PO Box 9034, UND Station, Grand Forks, ND 58202-9034. Telephone (701) 795-8423; Fax (701)795-8395.
Introduction
Dietary Boron and Body Growth
Much of the current interest in boron animal nutrition began in 1981 with the finding that physiologic amounts of boron (3 mg/kg diet), when added to diets low in boron content (
0.3 mg/kg diet), stimulated growth in vitamin D3-deficient (125 IU/kg) chicks. Boron supplementation did not markedly affect growth in chicks that received ample vitamin D3 nutriture of 2500 IU/kg (Table 1) (1). Vitamin D3 must be converted to metabolically active forms before it can function. The first obligatory enzymatic conversion to 25-hydroxyvitamin D3 occurs in the liver. In the kidney, a major site of 25-hydroxyvitamin D3 metabolism, an enzymatic reaction converts some of the circulating 25-
hydroxyvitamin D3 to 1,25-dihydroxyvitamin D3. 1,25-dihydroxyvitamin D3, the hormonal form of the vitamin, is degraded to calcitroic acid, which is thought to represent a major inactivation route of the hormone (2). The findings from the boron feeding study suggested that boron affected some aspect of vitamin D3 metabolism or was synergistic with vitamin D3 to influence growth.
In a subsequent series of experiments, the dietary concentrations of calcium or magnesium were manipulated to examine the interaction between dietary boron and vitamin D3. Magnesium deficiency was chosen as a stressor of vitamin D3 metabolism because the element is a cofactor for the hydroxylation of 25-hydroxycholecalciferol (OH) vitamin D3 (2). Findings from boron-calcium studies (Table 2) indicated that the effect of boron supplementation on growth in chicks was eliminated when dietary calcium was increased from 10 to 20 g/kg of diet (3). Findings from boron-magnesium studies (Table 3) indicated that growth in magnesium-deficient chicks (300 mg Mg/kg diet) increased with boron supplementation (3). The response was independent of vitamin D3 intake. However, the lowest amount of vitamin D3 supplementation (250 IU/kg) was higher than in earlier experiments. In general, comparison of the findings on growth from the boron-calcium and boron-magnesium studies suggested that the relationship between magnesium and boron was stronger than that between calcium or phosphorus and boron. However, the boron:magnesium molar ratio was quite low in both plasma and diet. Therefore, a direct effect of boron on magnesium metabolism was not suggested. Apparently, boron indirectly influences magnesium metabolism, and ultimately, calcium and phosphorus metabolism, by influencing an enzyme or hormone system.
The concentration of boron in the supplemented diets cited was similar to that found in a variety of diets that contained more natural than purified foodstuffs. Therefore, the growth response to boron supplementation was probably physiologic and not pharmacologic in nature. For example, the concentration of boron in alfalfa was reported to be as high as 42 mg boron/kg dry material (4). In a 10% alfalfa ration, the amount of boron contributed by the alfalfa component alone would increase the total boron concentration to 4.2 mg boron/kg dry material. Samples of Ralston Rodent Laboratory Chow #5001, a common diet for the laboratory rat, were found to contain 12.1 to 13.7 mg boron/kg (5). In several fruits and vegetables typically consumed by humans, the concentration of boron is at least 2 mg/kg wet weight of material (6). Therefore, it is reasonable to assume that a physiologic amount of boron was present in the experimental chick diets, an amount defined as one within a range of concentrations typically present in animal or human diets.
Animal Boron Nutrition Methodology
Prior to the findings published in 1981, all other animal boron nutrition studies were published between 1939 and 1947. Unfortunately, all of the earlier findings were confounded by the use of basal diets that were either nutritionally inadequate or supplemented with excessive amounts of boron (100-2200 mg/kg) (7-11). Most findings from the earlier studies suggested that supplemental boron did not affect measured variables, such as growth, even though most of the basal diets fed reportedly contained only 0.16 to 0.45 mg boron/kg. In one unconfirmed study (10), supplemental dietary boron (100-1000 mg boron/kg) enhanced survival and maintenance of body fat, and elevated liver glycogen in severely potassium-deficient rats. The unusual technical difficulties encountered in the execution of boron nutrition studies, which may have compromised the findings of the earlier studies, justify a brief summary of techniques used to overcome these difficulties. The physical and chemical characteristics of boron put special constraints upon diet formulations, boron kinetic studies, and verification of dietary boron content.
Diet Formulations
Care must be taken to ensure that basal diets for boron nutrition research are nutritionally balanced, but low in boron content. Because typical commercial diets often contain appreciable amounts of boron, additional supplements of dietary boron should have negligible impact on general metabolism. On the other hand, balanced animal diets low in boron content (<0.2 mg/kg) are not difficult to formulate. Animal muscle and milk products, and certain plant species within the subclass Monocotyledoneae, such as the gramineous grain crops (corn, rice, wheat, barley), contain low (<0.2 mg/kg) or negligible amounts of boron. Plant products from species within the subclass Dicotyledoneae, which includes fruits, nuts, and vegetables, are major sources of dietary boron (6,12). For chick or rat boron feeding studies, a well-balanced basal diet low in boron can be made from ground corn, high protein casein, and corn oil supplemented with certain minerals and vitamins (Tables 4-6). Sucrose is probably an acceptable carbohydrate source in boron test diets because it contains negligible amounts of boron (0.015 mg/kg) (6).
Because boron leaches readily from most laboratory glassware, neither drinking water nor liquid reagents used in boron biological research should come in contact with glassware for any length of time. For example, the brief time taken to quantify deionized water volume with a standard glass volumetric pipet is sufficient exposure to glass to increase the boron content of the water sample from background concentrations to concentrations found in plasma (0.025 µg/ml) (Hunt, unpublished observations).
The speciation of boron in foods has not been determined but is probably complex and dependent upon the nature of the integral ligands. If boron absorption mechanisms in plants and animals are analogous, the organic forms of boron per se are probably unavailable to animals (13). On the other hand, the strong association between polyhydroxyl ligands and boron is easily and rapidly reversed by dialysis, change in pH, heat, or the excess addition of another low-molecular-weight polyhydroxyl ligand (14). In all animal nutrition studies with boron conducted in this laboratory, boron was added to the experimental diets as orthoboric acid, because it is a common inorganic form of boron of high purity (99.9995%) that is absorbed well from the gastrointestinal tract (15).
Boron Kinetics
The determination of boron uptake, turnover, and excretion in animal model systems is hampered by the radiochemical properties of boron. The radioisotopes 8B, 12B, and 13B all have half-lives of less than one second. However, the two stable boron isotopes, 10B and 11B, are distributed unequally in nature (19.8 and 80.2%, respectively). As discussed in more detail elsewhere in this symposium, attempts are being made to exploit this phenomenon for the determination of boron body pool size and distribution by isotopic dilution and mass spectrometry.
Boron Analysis
The lack of affordable analytical capabilities of acceptable sensitivity is a major deterrent to boron nutrition research. Accurate determinations of low concentrations of boron in biological substances have proven exceptionally difficult. The analytical difficulty is exemplified by the fact that there is no current U.S. boron certified reference biomaterial. Analytical procedures commonly employed for trace element analysis are inappropriate for the determination of low concentrations of boron (<5.0 µg/g). Most forms of glassware and chemical reagents with background boron contamination must be avoided. Furthermore, many boron compounds volatize at temperatures far below those required for most dry-ash procedures, and the extreme volatility of boron-halide compounds exacerbates the problem. This author has developed an economical procedure for the digestion of biological substances prior to boron analysis by inductively-coupled argon plasma spectroscopy. The procedure circumvents many of the problems associated with boron analysis (16).
Guideposts to the Roles of Boron in Animal Species
It is well established that vascular plants, diatoms, and some species of marine algal flagellates have acquired an absolute requirement for boron (12,17). Even so, the primary role of boron in those organisms remains unknown. The diverse effects of boron deficiency on plant anatomy, physiology, and biochemistry suggest that the element has multiple functions. There is considerable evidence from in vitro studies with both plant and animal tissues that an important role of boron is metabolic regulation, because it complexes with a variety of substrate or reactant compounds in which there are hydroxyl groups in favorable positions (18). For example, two classes of enzymes are competitively inhibited in vitro by borate or its derivatives. One class, the oxidoreductase enzymes, which require pyridine or flavin nucleotides, are inhibited as borate competes for the NAD, or flavin cofactor. Some examples are aldehyde dehydrogenase (19), xanthine oxidase (20), and cytochrome b5 reductase (21). Borate apparently complexes with the ribosyl cis-hydroxy groups of NAD (22). The other class of enzymes forms transition state analogues with borate and boronic acid derivatives (23). Important examples are the serine proteases, several of which are key regulators of the normal inflammatory process. The coagulation factors Xa, IXa, XIa, XIIa, activated Hageman factor, and thrombin are serine proteases within the coagulation cascade, an integral component of the inflammatory process. There are at least three boronic acids which are highly effective, slow-binding inhibitors of thrombin (24).
Key pathways of energy substrate metabolism contain members of both classes of enzymes that are inhibited by boron. In the glycolytic pathway, glyceraldehyde-3-phosphate dehydrogenase [EC 1.2.1.12] (GPD), which is composed of four identical subunits, converts D-glyceraldehyde-3-phosphate to 1,3-diphosphoglycerate. ATP and NAD+ regulate GPD activity as the former dissociates the enzyme into dimers and/or monomers (25), and the latter promotes reassociation (26). Boron also may regulate the enzyme, as there is evidence from in vitro experiments that borate binds to a specific site(s) on the enzyme that triggers structural changes and dissociation of the tetramer (27). In addition to forming a transition-state-analogue with the enzyme, boron also interacts with the NAD cofactor associated with GPD (28). Competitive inhibition with respect to NAD+ is also observed for another NAD-requiring enzyme of the glycolytic pathway, lactate dehydrogenase.
The pentose-phosphate pathway in mammalian liver generates a major part of the NADPH required for, among other things, fatty acid synthesis (29). In leukocytes, the same pathway generates the NADPH required for respiratory burst, the process by which the cell produces oxidants for attack on malignant cells, invading organisms too large to be ingested, and certain soluble mediators. The NADPH requirement is met by the oxidation of glucose-6-phosphate in the pentose-phosphate pathway. In plants, one substrate of the pentose-phosphate pathway, 6-phosphogluconate, is known to complex with boron, which thereby inhibits 6-phosphogluconate dehydrogenase. Thus, in boron-deficient plants, there is an increase in the amount of substrate metabolized via the pentose-phosphate pathway, and a decrease in that metabolized via the Krebs
cycle (30).
The in vitro evidence for the inhibitory, and possibly regulatory, effects of boron on certain enzymes in energy substrate metabolism pathways, coupled with the finding that boron exerts an apparently beneficial effect on body growth, prompted further investigation of the possible role of boron in energy metabolism, especially during concomitant vitamin D3 deficiency. The well-known relationship between vitamin D3 and mineral/bone metabolism prompted investigation of the role of boron in bone morphology and metabolism as well. Thus, the effects of boron on various aspects of energy and mineral metabolism were examined simultaneously throughout the course of several experiments conducted in the author's laboratory. To facilitate discussion, those findings are reviewed separately here.
Boron, Vitamin D3, and Energy Substrate Utilization
Vitamin D3
Classical definitions of functional vitamin D deficiency do not adequately account for the dissociation between plasma-calcium concentrations, deficiency of vitamin D metabolites, and/or bone pathology under certain conditions (31). The complexity of vitamin D-deficiency disease is exemplified by the heterogeneity of pathologic conditions that characterize the disease, from diabetes to rickets, and by the number of intrinsic and extrinsic factors which either enhance or alleviate expression of vitamin D-deficiency. It was therefore important to determine whether dietary boron is a factor in the expression of the disease.
Other research showed that vitamin D3 influences energy substrate utilization as well as mineral metabolism. Rachitic chick bone that was incubated aerobically in vitro consumed more glucose and released more lactate than normal bone. When the rachitic bone was pretreated 48 hr with
vitamin D3, the rate of glycolysis returned to normal (32). This effect of vitamin D3 on glycolysis may have been mediated through calcium because calcium is one of the main inhibitors of phosphofructokinase (33), a rate-limiting enzyme in the glycolytic pathway. In rats, cellular glycolysis was doubled in rachitic cartilage compared to normal cartilage. There also was a corresponding increase in the activity of phosphofructokinase, aldolase, pyruvate kinase, and lactate dehydrogenase (34). In vitro consumption of glucose in rachitic chick bone was reduced markedly by the addition of vitamin D to the culture media (35). Patients with chronic renal failure, compared to age-and sex-matched controls, exhibited impaired glucose tolerance and hyperlipoproteinemia prior to therapy. Treatment with a synthetic analogue to active vitamin D reduced fasting blood-glucose concentrations and serum triglycerides, and improved glucose tolerance (36).
There is further evidence that vitamin D3 is important in energy substrate utilization. Findings from several studies with animals and humans indicate that vitamin D3 is essential for insulin secretion (37-40). Various vitamin D3 metabolites stimulated creatine kinase BB activity in kidney and long bone diaphyses (41). Also, dietary vitamin D3 deficiency reduced hepatic glycogen content in rats (42). In the same study, designed to
reexamine the hypothesis that lipid-
carbohydrate conversions do not occur in mammalian liver, liver slices from vitamin D3-adequate rats had a 35% increase in glycogen content after incubation with palmitate. Similar treatment of slices from the vitamin D3-deficient rats yielded no change in glycogen content. Other findings from the study indicated that vitamin D3 treatment of rachitic animals produced a 5- and 4-fold increase in the activity of two enzymes unique to the glyoxylate cycle, isocitrate lyase, and malate synthase.
Boron and Glucose Utilization
Because vitamin D3 regulates indices of energy substrate utilization, and boron improves body growth in vitamin D3-deficient chicks, several studies were conducted to determine whether an interaction between dietary boron and vitamin D3 modifies energy substrate utilization. There is now considerable evidence that glucose, the most thoroughly investigated metabolite to date, responds to physiologic supplements of dietary boron, especially during concomitant vitamin D3 deficiency. In an experiment designed to test interactions between boron, magnesium, and vitamin D3 (Table 7) (43), dietary boron (3.04 vs 0.04 mg/kg diet) decreased the abnormally elevated plasma-glucose concentrations by 29% in the vitamin D3-deficient animals but only by 6% in the vitamin D3-adequate control group. Further physiologic stress, introduced as magnesium deficiency, reversed the effect of dietary boron in the vitamin D3-deficient chicks. Similar effects of dietary boron on glucose metabolism in vitamin D3-deficient animals were noted in three other studies. In a study designed to test interactions among boron, magnesium, and molybdenum in vitamin D3-deficient chicks only (44), boron (3.47 vs 0.05 mg/kg diet) decreased plasma glucose by 21% in chicks fed either adequate amounts of magnesium and no molybdenum supplementation (29%) or inadequate magnesium and supplemental molybdenum (27%) (Table 8). Findings from a preliminary study (45) (Table 9) with vitamin D3-deficient chicks only indicated that the percent of decrease in plasma glucose concentration varied according to the amount of boron supplementation. Compared to a basal dietary boron concentration of 0.20 mg/kg, boron concentrations of 0.25, 0.33, 0.48, 1.23, 2.10, and 3.97 decreased glucose concentrations by 9, 30, 34, 29, 33, and 21%, respectively. Second-order regression analysis of the glucose values vs boron intake described a parabola whose critical value (slope equals 0) occurred around the point where the milligram of boron per kilogram of diet equaled 1.00. In vitamin D3-deprived rats, there was a trend for boron supplementation to decrease plasma glucose concentrations (149 vs 134 mg/dl) (46). Finally, a study with humans who were fed a low-magnesium diet showed that a daily dietary intake of 3.23 mg boron for 49 days, compared to a daily intake of 0.23 mg for 63 days, decreased serum glucose concentrations (in the normal range) approximately 6% (88 vs 94 mg/dl; p<0.007) in postmenopausal women (47). In the same study, male volunteers exhibited no response to supplemental dietary boron.
Other findings suggest that boron modulates hepatic glycolysis, particularly when vitamin D3 intake is inadequate. Dietary boron (2.25 vs 0.16 mg/kg) lowered concentrations of the glycolytic metabolites fructose-1,6-diphosphate-P2, glycerate-2P, and (OH)2-acetone P in freeze-clamped chick liver (Table 10) (48). Furthermore, the vitamin D3-deprived rat that is fed supplemental boron (2.0 mg/kg) exhibits reduced plasma pyruvate concentrations (46). In summary, the evidence to date suggests that boron acts as a regulator of energy substrate utilization by quenching the activity of some enzymes and/or stabilizing reactive compounds.
Boron, Vitamin D3, and Mineral/Growth Cartilage Metabolism
Bone Metabolism
There is evidence that initiation of cartilage calcification is dependent upon the energy charge of the chondrocyte. For example, in chick epiphysial growth cartilage, creatine kinase activity is related to chondrocyte maturation because activity increases with cell hypertrophy. Creatine phosphate concentrations are highest in the proliferative zone and are nondetectable in calcified cartilage as compared to amounts present in resting and hypertrophic zones (49). Mineralization of chick growth cartilage begins in the perivascular region of the marrow sprouts, a region of hypertrophic cartilage that has a higher level of oxidative metabolism than chondrocytes greater than 150 µm from the vascular channels (50). Also, redox studies of chick epiphyseal growth cartilage show that the NAD/NADH ratio is much higher in proliferative than hypertrophic cartilage (51).
Vitamin D3 and Bone Metabolism
The rachitic chick, compared to the vitamin D3-adequate chick, exhibits decreased creatine kinase activity in the hypertrophic cartilage of the growth plate (49). In both the proliferative and hypertrophic zones, the induction of rickets causes a large decrease in the actual concentration of NAD and NADH, as well as a perturbation in the ratio between the two. Administration of vitamin D to the rachitic birds induces a rapid increase in NAD and NADH in all zones of the growth cartilage (51).
The findings that initiation of cartilage calcification is energy dependent, and that vitamin D3 regulates the energy charge of the chondrocyte, support the thesis that the influence of vitamin D3 on cartilage and bone mineralization is mediated through its role as a regulator of energy substrate utilization. There are two important corollaries to the vitamin D3-energy thesis. First, calcification is an energy intensive process. Second, factors that modulate energy metabolism also affect bone and mineral metabolism.
Boron and Growth
Cartilage Metabolism
There is evidence that dietary boron modulates growth-cartilage metabolism. In the vitamin D3-deficient chick, an interaction between dietary boron and magnesium affected the histology of the tibial epiphysial growth plate (Table 8) (44). Calcification of growth-plate cartilage matrix normally begins distal to the tips of marrow sprouts that invade the hypertrophic zone of growth cartilage from the metaphysis as a parallel array of straight excavations. The distance between the tips of the marrow sprouts and the first appearance of calcified matrix is a convenient measure of the mineralization rate. In the vitamin D3-deficient chick, also stressed with magnesium inadequacy, boron supplementation inhibited the initiation of cartilage calcification, but enhanced body growth. When the chicks were supplied with adequate dietary magnesium, supplemental boron enhanced initiation of cartilage calcification and reduced body growth. The findings indicated that physiologic amounts of boron may function to modify mineral
metabolism in vitamin D3 deficiency by suppressing bone anabolism in magnesium deficiency and bone catabolism in magnesium adequacy. The effects of boron on cartilage calcification seem beneficial in both magnesium inadequacy and adequacy because the vitamin D3 deficiency-induced mortality was substantially reduced by dietary boron. Furthermore, supplemental boron alleviated distortion of the marrow sprouts, a distortion characteristic of vitamin D3 deficiency. Other findings from a different laboratory indicate that in ovo injections of boron or 1,25-(OH)2 vitamin D3 reduced the abnormal height of the growth plate of one-day-old chicks hatched from vitamin D3-deficient eggs (52).
Boron and Mineral Metabolism
Dietary boron also affects mineral metabolism in blood and tissues. In the vitamin D3-deficient chick, an interaction between dietary boron and magnesium affected calcium and magnesium concentrations in plasma but not in femora (Table 11) (44). Thus, in the vitamin D3-deficient chick, also stressed with magnesium inadequacy, boron supplementation elevated plasma calcium and magnesium concentrations. When the chicks were supplied with adequate dietary magnesium, supplemental boron had the opposite effect on those plasma mineral concentrations.
Heart mineral metabolism is also responsive to physiologic amounts of dietary boron (Table 12) (52). In the vitamin D3-deprived rat, supplemental boron depressed cardiac calcium but elevated cardiac phosphorus concentrations. Supplemental boron also elevated cardiac manganese and molybdenum concentrations in vitamin D3-deprived rats, but depressed those concentrations in littermates stressed with an injection of streptozotocin. The streptozotocin injection induced an acute phase of experimental diabetes characterized by decreased intestinal absorption of calcium (31) and low concentrations of plasma 1,25-(OH)2 vitamin D3 (54). Dietary boron probably had an indirect effect on cardiac mineral metabolism because supplemental boron did not affect cardiac boron concentrations (not shown).
Boron bone content correlated with potassium and zinc concentrations in iliac cortical bone samples, obtained from men and women (62 ± 11 years) who suffered from severe, untreated osteoporosis, with at least one collapsed vertebra (55). The investigators reported a negative boron-potassium correlation and a positive boron-zinc correlation. Analysis of bone from age-matched normal controls showed no correlation between either element and boron. Except for a positive correlation between magnesium and boron in the normal subjects, there were no other correlations between any two elements, although several bone minerals were analyzed (aluminum, calcium, copper, fluorine, iron, potassium, magnesium, phosphorus, lead, silicon, strontium, and zinc). Finally, in vitamin D-deficient rats, supplemental dietary boron improved the apparent absorption and retention of calcium and phosphorus, and increased femur magnesium concentrations (55).
Summary
There is considerable evidence that physiologic amounts of dietary boron modulate both energy substrate utilization and mineral metabolism. Vitamin D3 regulates energy substrate utilization. Current research findings indicate that dietary boron modifies that regulatory function. The influence of vitamin D3 on growth-cartilage mineralization is mediated at least in part through its role as a regulator of energy substrate utilization; calcification is an energy-intensive process. There is considerable evidence that dietary boron alleviates perturbations in mineral metabolism that are characteristic of vitamin D3 deficiency. The findings described herein lend support to the hypothesis that boron alleviates the symptoms of vitamin D3 deficiency by enhancing utilization or sparing minimal supplies of an active vitamin D3 metabolite. Also, boron and vitamin D3 have the same overall effect on the local utilization of energy substrates. A corollary of the hypothesis is that some of the effects of dietary boron will be overshadowed by the effects of adequate amounts of dietary vitamin D3.
References
1. Hunt C, Nielsen F. Interaction between boron and cholecalciferol in the chick. In: Trace Element Metabolism in Man and Animals-4. (Gawthorne J, White C, eds). Canberra: Australian Academy of Science, 1981;597-600.
2. DeLuca H, Schnoes H. Vitamin D: recent advances. Annu Rev Biochem 52:411-439 (1983).
3. Hunt C, Shuler T, Nielsen F. Effect of boron on growth and mineral metabolism. In: 4. Spurenelement-Symposium (Anke M, Baluman W, Braunlich H, Bruckner C, eds). Jena, German Democratic Republic: Friedrich-Schiller University, 1983;149-155.
4. Pau J-M, Pickett E, Koirtyohann S. Determination of boron in plants by emission spectroscopy with the nitrous oxide-hydrogen flame. Analyst 97:860-865 (1972).
5. Hunt C, Halas E, Eberhardt M. Long-term effects of lactational zinc deficiency on bone mineral composition in rats fed a commercially modified Luecke diet. Biol Trace Elem Res 16:97-113 (1988).
6. Hunt C, Shuler T, Mullen L. Concentration of boron and other elements in human foods and personal-care products. J Am Diet Assoc 91:558-568 (1991).
7. Teresi J, Hove E, Elvehjem C, Hart E. Further study of boron in the nutrition of the rat. Am J Physiol 140: 513-518 (1944).
8. Orent-Keiles E. The role of boron in the diet of the rat. Proc Soc Exp Biol Med 44:199-202 (1941).
9. Hove E, Elvehjem C, Hart E. Boron in animal nutrition. Am J Physiol 127:689-701 (1939).
10. Skinner J, McHargue J. Response of rats to boron supplements when fed rations low in potassium. Am J Physiol 143:385-390 (1945).
11. Follis R. The effect of adding boron to a potassium-deficient diet in the rat. Am J Physiol 150:520-522 (1947).
12. Loomis W, Durst R. Chemistry and biology of boron. BioFactors 3:229-239 (1992).
13. Gupta U, James Y, Campbell C, Leyshon A, Nicholaichuk W. Boron toxicity and deficiency: a review. Can J Soil Sci 65:381-409 (1985).
14. Zittle C. Reaction of borate with substances of biological interest. In: Advances in Enzymology, vol 12 (Ford F, ed). New York:Interscience Publishers, 1951; 493-527.
15. Pfeiffer C, Jenney E. The pharmacology of boric acid and boron compounds. Bull Natl Formulary Comm 18: 57-74 (1950).
16. Hunt C, Shuler T. Open-vessel, wet-ash, low-temperature digestion of biological materials for inductively coupled argon plasma spectroscopy (ICAP) analysis of boron and other elements. J Micronutr Anal 6:161-174 (1989).
17. Lovatt C. Evolution of xylem resulted in a requirement for boron in the apical meristems of vascular plants. New Phytol 99:509-522 (1985).
18. Dugger W. Boron in plant metabolism. In: Encyclopedia of plant physiology, inorganic plant nutrition, vol 15 (Läuchli A, Bielesk R, eds). Berlin:Springer-Verlag, 1983; 626-650.
19. Deitrich R. Diphosphopyridine nucleotide-linked aldehyde dehydrogenase. III. Sulfhydryl characteristics of the enzyme. Arch Biochem Biophys 119:253-263 (1967).
20. Roush A, Norris E. The inhibition of xanthine oxidase by borates. Arch Biochem Biophys 29:344-347 (1950).
21. Strittmatter P. Reversible direct hydrogen transfer from reduced pyridine nucleotides to cytochrome b5 reductase. J Biol Chem 239:3043-3050(1964).
22. Johnson S, Smith K. The interaction of borate and sulfite with pyridine nucleotides. Biochemistry 15:553-559 (1976).
23. Lindquist R, Terry C. Inhibition of subtilisin by boronic acids, potential analogs of tetrahedral reaction intermediates. Arch Biochem Biophys 160:135-144 (1974).
24. Kettner C, Mersinger L, Knabb R. The selective inhibition of thrombin by peptides of boroarginine. J Biol Chem 265:18289-18297 (1990).
25. Constantinides S, Deal WJ. Reversible dissociation of tetrameric rabbit muscle glyceraldehyde 3-phosphate dehydrogenase into dimers or monomers by adenosine triphosphate. J Biol Chem 244:5695-5702 (1969).
26. Deal WJ. Metabolic control and structure of glycolytic enzymes IV. Nicotinamide-adenine dinucleotide dependent in vitro reversal of dissociation and possible in vivo control of yeast glyceraldehyde 3-phosphate dehydrogenase synthesis. Biochemistry 8:2795-2805 (1969).
27. Suzuki K, Hibino K, Imahori K. Hybridization of glyceraldehyde-3-phosphate dehydrogenase in borate. J Biochem 79:1287-1295(1976).
28. Smith K, Johnson S. Borate inhibition of yeast alcohol dehydrogenase. Biochemistry 15:560-565 (1976).
29. Zubay G. Biochemistry. New York:Macmillan, 1988:670-673.
30. Lovatt C, Dugger W. Boron. In: Biochemistry of the Essential Trace Elements (Frieden E, ed). New York:Plenum Press, 1984; 389-421.
31. Walters M, Kollenkirchen U, Fox J. What is vitamin D deficiency? Proc Soc Exp Biol Med 199:385-393 (1992).
32. Schneider L, Schedl H. Diabetes and intestinal calcium absorption in the rat. Am J Physiol 223:1319-1323 (1972).
33. Auffermann W, Wagner S, Wu S, Buser P, Parmley W, Wikman-Coffelt J. Calcium inhibition of glycolysis contributes to ischaemic injury Cardiovasc Res 24: 510-520 (1990).
34. Meyer W, Kunin A. The inductive effect of rickets on glycolytic enzymes of rat epiphyseal cartilage and its reversal by vitamin D and phosphate. Arch Biochem Biophys 129:438-446 (1969).
35. Paterson C, Fourman P. Collagen synthesis and carbohydrate metabolism of rachitic bone. Biochem J 109: 101-106 (1968).
36. Lind L, Lithell H, Wengle B, Wrege U, Ljunghall S. A pilot study of metabolic effects of intravenously given alpha-calcidol in patients with chronic renal failure. Scand J Urol Nephrol 22:219-222 (1988).
37. Norman A, Heldt A, Grodsky G. Vitamin D deficiency inhibits pancreatic secretion of insulin. Science 209: 823-825 (1980).
38. Frankel B, Sehlin J, Täljedal I-B. Vitamin D3 stimulates calcium-45 uptake by isolated mouse islets in vitro. Acta Physiol Scand 123:61-66 (1985).
39. Kadowaki S, Norman A. Demonstration that the vitamin D metabolite 1,25(OH)2-vitamin D3 and not 24R,25(OH)2-vitamin D3 is essential for normal insulin secretion in the perfused rat pancreas. Diabetes 34:315-320 (1985).
40. Gedik O, Akalin S. Effects of vitamin D deficiency and repletion on insulin and glucagon secretion in man. Diabetologia 29:142-145 (1986).
41. Somjen D, Weisman Y, Binderman I, Kaye A. Stimulation of creatine kinase BB activity in 1 alpha-25-dihydroxycholecalciferol and 24R,25-dihydroxycholecalciferol in rat tissues. Biochem J 219:1037-1041 (1984).
42. Davis W, Matthews J, Goodman D. Glyoxylate cycle in the rat liver: effect of vitamin D3 treatment. FASEB J 3:1651-1655 (1989).
43. Hunt C, Nielsen F. Interactions among dietary boron, magnesium, and cholecalciferol in the chick. Proc ND Acad Sci 41:50 (1987).
44. Hunt C. Dietary boron modified the effects of magnesium and molybdenum on mineral metabolism in the cholecalciferol-deficient chick. Biol Trace Elem Res 22: 201-220 (1989).
45. Hunt C. Boron homeostasis in the cholecalciferol-deficient chick. Proc ND Acad Sci 42:60 (1988).
46. Hunt C, Herbel J. Boron affects energy metabolism in the streptozotocin-injected, vitamin D3-deprived rat. Mag Trace Elem 10:374-386 (1991-1992).
47. Nielsen F. Dietary boron affects variables associated with copper metabolism in humans. In: 6th International Trace Element Symposium 1989, vol. 4 (Anke M, Baumann W, Bräunlich H, Brückner C, Groppel B, Grün M, eds). Leipzig:Karl-Marx Universitat, 1989; 1106-1111.
48. Muessig K, Hunt C. The effects of dietary boron, vitamin D3, and their interaction on glycolytic metabolites in chicks. Proc ND Acad Sci 45:25 (1991).
49. Shapiro I, Debolt K, Funanage V, Smith S, Tuan R. Developmental regulation of creatine kinase activity in cells of the epiphyseal growth cartilage. J Bone Miner Res 7:493-500 (1992).
50. Shapiro I, Golub E, Chance B, Piddington C, Oshima O, Tuncay O, Frasca P, Haselgrove J. Linkage between energy status of perivascular cells and mineralization of the chick growth cartilage. Develop Biol 129:372-379 (1988).
51. Kakuta S, Golub E, Haselgrove J, Chance B, Frasca P, Shapiro I. Redox studies of the epiphyseal growth cartilage: pyridine nucleotide metabolism and the development of mineralization. J Bone Miner Res 1:433-446 (1986).
52. King N, Odom T, Sampson H, Yersin A. The effect of in ovo boron supplementation on bone mineralization of the vitamin D-deficient chicken embryo. Biol Trace Elem Res 31:223-233 (1991).
53. Hunt C, Herbel J. Effects of dietary boron on calcium and mineral metabolism in the streptozotocin-injected, vitamin D3-deprived rat. Mag Trace Elem 10:387-408 (1991-1992).
54. Schneider L, Schedl H, McCain T, Haussler M. Experimental diabetes reduces circulating 1,25-dihydroxyvitamin D in the rat. Science 196:1452-1454 (1977).
55..Basle M, Mauras Y, Audran M, Clochon P, Rebel A, Allain P. Concentration of bone elements in osteoporosis. J Bone Miner Res 5:41-47 (1990).
56. Hegsted M, Keenan M, Siver F, Wozniak P. Effect of boron on vitamin D deficient rats. Biol Trace Elem Res 28:243-256 (1991).
Last Update: November 7, 1998
